Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Ivacaftor-D9 (Synonyms: VX-770-d9, deutivacaftor, CTP-656)

Catalog No. T27098 Copy Product Info
Purity: 99.13%
🥰Excellent
Ivacaftor-D9 is transmembrane conductance regulator (CFTR) channel activator, is used potentially for the treatment of cystic fibrosis.

Ivacaftor-D9

Copy Product Info
🥰Excellent
Catalog No. T27098
Synonyms VX-770-d9, deutivacaftor, CTP-656

Ivacaftor-D9 is transmembrane conductance regulator (CFTR) channel activator, is used potentially for the treatment of cystic fibrosis.

Ivacaftor-D9
Cas No. 1413431-07-8
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$123-In Stock
5 mg$297-In Stock
10 mg$519-In Stock
25 mg$832-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.13%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Ivacaftor-D9 is transmembrane conductance regulator (CFTR) channel activator, is used potentially for the treatment of cystic fibrosis.
Targets&IC50
CFTR:255 nM (EC50)
In vivo
In pharmacokinetic studies, male Sprague‑Dawley rats exhibited favorable pharmacokinetic profiles following a single oral dose of 10 mg/kg Ivacaftor-D9. Plasma drug concentrations were monitored for 72 hours, with the main parameters as follows: Cmax 1970 ng/mL (CV 15%), AUC₀₋₂₄h 24260 h·ng/mL (CV 17%), C₂₄h 413 ng/mL (CV 19%), and t₁/₂ 13.9 h.
In male beagle dogs, following a single oral dose of 3 mg/kg Ivacaftor-D9, the corresponding pharmacokinetic parameters were: Cmax 3643 ng/mL (CV 9%), AUC₀₋₂₄h 49782 h·ng/mL (CV 31%), C₂₄h 1418 ng/mL (CV 31%), and t₁/₂ 22.8 h.
SynonymsVX-770-d9, deutivacaftor, CTP-656
Chemical Properties
Molecular Weight401.55
FormulaC24H19D9N2O3
Cas No.1413431-07-8
SmilesC(C)(C)(C)C1=C(NC(=O)C=2C(=O)C=3C(NC2)=CC=CC3)C=C(O)C(C(C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])=C1
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 40 mg/mL (99.61 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.4903 mL12.4517 mL24.9035 mL124.5175 mL
5 mM0.4981 mL2.4903 mL4.9807 mL24.9035 mL
10 mM0.2490 mL1.2452 mL2.4903 mL12.4517 mL
20 mM0.1245 mL0.6226 mL1.2452 mL6.2259 mL
50 mM0.0498 mL0.2490 mL0.4981 mL2.4903 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Ivacaftor-D9 | purchase Ivacaftor-D9 | Ivacaftor-D9 cost | order Ivacaftor-D9 | Ivacaftor-D9 chemical structure | Ivacaftor-D9 in vivo | Ivacaftor-D9 formula | Ivacaftor-D9 molecular weight